MERGERS AND ACQUISITIONSJohnson & Johnson Looks for New Deal That's Just RightBy Alicia McElhaneyDec 15, 2016 7:30 AM EST
JIM CRAMERJim Cramer's 'Mad Money' Recap: Here's How Oil, the Fed and China Pushed Markets UpBy Scott RuttAug 27, 2015 8:22 PM EDT
MARKETSAbbVie (ABBV) Stock Gains After IMBRUVICA Receives EU Regulatory ApprovalBy Tony OwusuJul 10, 2015 3:37 PM EDT
INVESTINGJim Cramer -- Here's Why I'm Buy, Buy, Buying J&J and Selling MerckBy Jim CramerMay 26, 2015 2:27 PM EDT
MARKETSAbbVie (ABBV) Stock Gains After Completing $21 Billion Pharmacyclics PurchaseBy Tony OwusuMay 26, 2015 12:42 PM EDT
VIDEOCramer: I'm Buying J&J as It Has the Most Upside of Major PharmasBy Jim CramerMay 26, 2015 12:34 PM EDT
INVESTINGJim Cramer -- Stock Market's Takeover Frenzy Won't End Anytime SoonBy Jim CramerMay 19, 2015 9:34 AM EDT
INVESTINGJim Cramer -- Why Is Janet Yellen Suddenly a Stock Commentator?By Jim CramerMay 7, 2015 9:01 AM EDT
MERGERS AND ACQUISITIONSAbbVie Refiles for Antitrust Review of Pharmacyclics DealBy Scott StuartApr 20, 2015 7:12 PM EDT
MARKETSJohnson & Johnson (JNJ) Stock Climbing Today on Better Than Expected First Quarter EarningsBy Kurumi FukushimaApr 14, 2015 8:37 AM EDT
MARKETSWhat to Expect When Johnson & Johnson (JNJ) Reports First-Quarter Earnings TomorrowBy Andrew MeolaApr 13, 2015 3:17 PM EDT
MARKETSAbbVie (ABBV) Stock Opens Higher, Then Falls Today Following Analyst UpgradeBy Andrew MeolaApr 13, 2015 1:36 PM EDT
MERGERS AND ACQUISITIONSFirst-Quarter Deals Near $1 Trillion Mark Highest Value Since 2007By Jaewon KangApr 13, 2015 11:47 AM EDT
INVESTINGJim Cramer -- Mylan's Move to Acquire Perrigo a Prescription for SuccessBy Jim CramerApr 9, 2015 7:00 AM EDT
INVESTINGBiotech Merger Monday Doesn't Squash Biotech Bubble DebateBy Adam FeuersteinMar 30, 2015 10:43 AM EDT
INVESTINGBiotech, Chips Stand Their Ground; Be Careful What You Wish For: Jim Cramer's Best BlogsBy Jim CramerMar 28, 2015 3:19 PM EDT
INVESTINGBioMarin Rises Amid Takeover Speculation, Price Target RaisesBy The Fly StaffMar 27, 2015 10:37 AM EDT
STOCKSBiotech Stocks Are Selling Off Just Like 2014 -- and That Might Be a Good ThingBy Adam FeuersteinMar 26, 2015 7:17 AM EDT
INVESTINGJim Cramer Digs Into Dozens of Charts, Finds 7 Pillars of Health Care StrengthBy Jim CramerMar 23, 2015 2:18 PM EDT
